Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00618033 · ClinicalTrials.gov registry record · NA
Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients
A NA study of ESRD and Hemodialysis, sponsored by Renal Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT00618033: Completed NA study of ESRD and Hemodialysis, sponsored by Renal Research Institute.
NCT00618033 is a NA study of ESRD and Hemodialysis that has completed, run by Renal Research Institute. The registered enrollment target is 30 participants, below the 138-participant average among 13 other ESRD trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00618033, a NA study of ESRD and Hemodialysis, has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to show that using a glucose (sugar) concentration of 100 mg/dL in the dialysis fluid for hemodialysis is not inferior to using a concentration of 200 mg/dL with regard to the frequency and magnitude of blood glucose drops. Other parameters that will be compared between the two groups are blood pressure, heart rhythm, weight gain between dialysis treatments, and fatigue after the treatment.
Conditions Studied
Interventions
- PROCEDURE Hemodialysis
Study Locations (2)
New York
- Irving Place Dialysis Center - New York
- Yorkville Dialysis Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00618033 record still lists
NCT00618033 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 138-participant average among 13 other ESRD trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with ESRD appearing as the primary indexed condition, and to 1 intervention - of which Hemodialysis is the first listed.
NCT00618033 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00618033 about?
NCT00618033 is a clinical study titled "Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients". This study aims to show that using a glucose (sugar) concentration of 100 mg/dL in the dialysis fluid for hemodialysis is not inferior to using a concentration of 200 mg/dL with regard to the frequency and magnitude of blood glucose drops. Other parameters that will be compared between the two group...
What is the current status of trial NCT00618033?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2008-02. Estimated completion is 2008-08.
What conditions does trial NCT00618033 study?
This clinical trial studies the following conditions: ESRD, Hemodialysis.
What interventions are being tested in trial NCT00618033?
The interventions under investigation include: Hemodialysis (PROCEDURE).
Who is sponsoring clinical trial NCT00618033?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00618033 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ESRD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00618033's enrollment target sits among peer trials
30 12th of 13 higher than 2 of 13 other ESRD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ESRD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Repletion of Ergothioneine in Patients With Kidney Failure
RECRUITING · NA
-
Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR
COMPLETED · NA
-
Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT
COMPLETED · NA
-
Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia